Trademark: 97003850
Word
REIMAGINE CARE
Status
Registered
Status Code
700
Status Date
Tuesday, April 4, 2023
Serial Number
97003850
Registration Number
7020321
Registration Date
Tuesday, April 4, 2023
Mark Type
4000
Filing Date
Tuesday, August 31, 2021
Published for Opposition
Tuesday, August 9, 2022

Trademark Owner History

Classifications
35 Business consulting and management in the field of clinical trials, namely, providing information management services in partnership with pharmaceutical companies and clinical research organizations (CROs) to administer and monitor oncology clinical trials at patients' homes, contract clinical trials into value-based care contracts and provide clinical trial access to diverse patient populations for clinical trial participation, accelerate trial completion, and lower trial costs
45 Providing personal support services for patients and families of patients undergoing cancer treatment, namely, emotional counseling and emotional support through volunteers in the community who include cancer survivors, as well as family members and friends of cancer patients
44 Analysis of oncology medical information for the treatment of cancer in the home on behalf of patients and cancer care providers, including analysis of value-based care, care coordination, decision-making services, and insights, as well as the evaluation of oncology clinical research studies for patient access and participation in clinical trials; medical services in the field of oncology, namely, providing oncology infusion therapy and oral oncolytic in alternative settings; medical services, namely, providing real-time symptom management and telemedicine triage via a dedicated multi-disciplinary oncology care team to optimize adverse cancer patient events and reactions to cancer
42 Platform as a service (PAAS) featuring computer software platforms for providing oncology hospital at home technology-enabled services in the nature of monitoring medication administration and dosage, assessing and reporting on pain levels for supporting oncologists and other healthcare providers in delivering high-quality, lower-cost, patient-centric cancer care; conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of cancer diagnosis and treatment, namely, partnering with pharmaceutical companies and clinical research organizations (CROs) to administer and monitor oncology clinical trials at patients' homes, contract clinical trials into value-based care contracts and provide clinical trial access to diverse patient populations for clinical trial participation, accelerate trial completion, and lower trial costs; Platform as a service (PAAS) featuring computer software platforms for monitoring, analyzing, assessing, transmitting patient medical and healthcare data to inform cancer care delivery optimization to patients and cancer care providers through a value-based care logistics management platform to efficiently and effectively manage workforce staffing, patient care, and pharmaceutical supplies required in alternative cancer delivery models; Platform as a service (PAAS) featuring computer software platforms for providing a comprehensive oncology clinical management solution, namely, medication administration and management, supportive care, lab testing, pain management, day-after-chemo injection of colony-stimulating factor drugs, advanced care planning, and at-home palliative care; Platform as a service (PAAS) featuring computer software platforms for providing cancer patients extensive cancer care navigation services in the nature of providing coordinated care by assessing, triaging, follow-up and supporting patients 24/7 and on-demand, for keeping patients with compromised immune function out of institutional settings and treating them in the convenience of their homes

Trademark Events
Jul 12, 2023
Automatic Update Of Assignment Of Ownership
Apr 4, 2023
Notice Of Registration Confirmation Emailed
Apr 4, 2023
Registered-Principal Register
Feb 25, 2023
Notice Of Acceptance Of Statement Of Use E-Mailed
Feb 24, 2023
Allowed Principal Register - Sou Accepted
Jan 30, 2023
Statement Of Use Processing Complete
Dec 30, 2022
Use Amendment Filed
Jan 30, 2023
Case Assigned To Intent To Use Paralegal
Dec 30, 2022
Teas Statement Of Use Received
Oct 4, 2022
Noa E-Mailed - Sou Required From Applicant
Aug 9, 2022
Official Gazette Publication Confirmation E-Mailed
Aug 9, 2022
Published For Opposition
Jul 20, 2022
Notification Of Notice Of Publication E-Mailed
Jul 6, 2022
Approved For Pub - Principal Register
Jun 22, 2022
Teas/Email Correspondence Entered
Jun 22, 2022
Correspondence Received In Law Office
Jun 22, 2022
Teas Response To Office Action Received
Jun 7, 2022
Notification Of Non-Final Action E-Mailed
Jun 7, 2022
Non-Final Action E-Mailed
Jun 7, 2022
Non-Final Action Written
Jun 6, 2022
Assigned To Examiner
Feb 4, 2022
Teas Change Of Correspondence Received
Feb 4, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 4, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 14, 2021
New Application Office Supplied Data Entered
Sep 3, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24